TGF-Beta 3: Partner Ciba-Geigy began a Phase I trial in healthy volunteers to assess tolerability of multiple applications to intact skin

Oncogene Sciences Inc. (ONCS), Uniondale, N.Y. Product: TGF-Beta 3, regulator of cell proliferation and differentiation Indication: Chronic skin wounds Status: Partner Ciba-Geigy began a Phase I trial...